Nephrocare Health Services Q1 FY27 Revenue Up 23.7% YoY to ₹281.8 Cr

Nephrocare Health Services Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Consolidated revenue for Q1FY27 stood at ₹281.8 crore, a 23.7% increase year-on-year. Adjusted EBITDA grew by 30.7% YoY to ₹65.1 crore, with margins expanding to 23.1%. Adjusted PAT increased by 41.7% YoY to ₹36.8 crore. Operational highlights include a 13.3% YoY increase in treatments to 10.31 lakh and a 9.2% YoY improvement in revenue per treatment to ₹2,733. The company's network expanded to 550 clinics across five countries.